Yesterday, Empire Metals Limited (EEE), the resource exploration and development company, said it would like to respond to recent sharp decline in the Company’s share price and would like to clarify that there has been no material change to the Company’s operational or financial position to account for this movement.
The Board remains confident in the Company’s strategy, the progress being made at the Pitfield Titanium Project and the long-term value proposition for shareholders.
Comment: A couple of weeks ago I received an email asking whether EEE had hit the end of Stage 1 of the Lassonde Curve, and was due for a correction? This was perhaps one of the most intelligent and well-timed questions I have ever received. Interesting that the company has not said the reason for the share price fall is due to the brilliance of the Lassonde theory.
Gold from Waste: How Panther Metals and Fulcrum Metals are Turning Tailings into Value
Fulcrum Metals (FMET), a company pioneering the use of innovative technology to recover precious and critical metals from mine waste, announced the start of phase 3 optimisation gold and silver development work with Extrakt Process Solutions LLC at the Teck-Hughes mine tailings project at Kirkland Lake, Ontario. FMET said “The positive outcome of the Phase 1 high-level gold recovery investigation and the Phase 2 conceptual study, enable us to commission Phase 3 with Extrakt.”
Comment: FMET has been understandably proud of the Extrakt partnership and show off how much it is helping the company progress Kirkland Lake. It is also pleasing that the share price now responds well to significant news such as today’s.
Cobra (COBR), the mineral exploration and development company, announced final results from the re-analysis of historical, uranium-focused rotary mud drilling from recently acquired tenements (EL 6742, EL 6774 and EL 6780, together the “New Tenements”) that expand the resource potential of Boland across two regionally extensive palaeochannel systems. COBR said “These results demonstrate the potential that these tenements add to the Boland Project. When the New Tenements transaction is finalised, we will be prepared for quick deployment to drill test these highly exciting targets which we believe will add considerable scale to the future Mineral Resource Estimate.”
Comment: COBR not only continues to enjoy the great revival in the rare earths area due to China / tariffs, it is finessing its position on the operational front. This is something which the market continues to appreciate in share price terms.
Lexington Gold (LEX), the gold exploration and development company with projects in South Africa and the USA, announced highly encouraging assay results from its latest diamond core drilling programme at the Jennings-Pioneer Project in South Carolina, USA. LEX said “These latest results are highly encouraging and further demonstrate the strong growth potential of the Jennings-Pioneer Project. At Barite Hill, step-out drilling has extended both the Red Hill and Middle Zones, which remain open along strike and at depth. This confirms the continuity of gold mineralisation along this historic trend and includes substantial shallow intersections grading above 2 g/t. Equally exciting is the maiden gold discovery at the Jennings Trend.”
Comment: LEX is well aware that delivering consistent newsflow at a time when gold is soaring is going to be appreciated. That said, the shares remain within recent ranges, so those seeking value in the space may yet pick on this company.
Premier African Minerals (PREM) provided a further update on the plant status at the Zulu Lithium and Tantalum Project following completion of the commissioning test phase as announced on 20 August 2025. PREM said “This next phase is a fundamental step in the ongoing validation process of the operating capacity of the Zulu plant. Demonstrating the ability to consistently float material at grade over sustained periods is essential to ensuring that all operational aspects are aligned for the future of Zulu. These results will provide the foundation for growth, whether through new investment or additional off-take funding, as those discussions with potential funders continue to advance.”
Comment: While we mourn the departure of George Roach, it would appear that the company is still kicking the tyres at the Zulu plant, which seems to be a project that so complicated and so problematic it would have had Isambard Kingdom Brunel scratching his head. That said, noises regarding off-takers / funding should support the share price ahead of the next placing.
Advanced Medical Solutions Group (AMS), the world-leading specialist in tissue-healing technologies, today announced its unaudited interim results for the six months ended 30 June 2025. Group revenue increased by 63% to £110.8 million and by 66% at constant currency (2024 H1: £68.0 million) with organic growth supplemented by the impact of the Peters Surgical acquisition that completed 1st July 2024. Adjusted EBITDA increased by 42% to £24.4 million (2024 H1: £17.2 million) with adjusted EBITDA margin at 22.0% (2024 H1: 25.3%). AMS said “Integration of last year’s acquisitions remain on track, with improvements to systems and manufacturing being made to reduce backorders, emerging commercial synergies in geographies, such as France and India, and in specialty areas, such as cardiovascular, set to strengthen H2 2025 and beyond. We are also making solid progress toward upcoming US product launches. We believe these initiatives will significantly enhance our earnings growth potential over the medium to long-term.”
Comment: A humdinger of an update from an under the radar company, in a non-sexy space. That said, AMS is a contender at £460m for being a company which transitions from being a mid-cap to a blue chip, and the shares appear to be merely at the foothills.
Hemogenyx Pharmaceuticals (HEMO) announced that the third patient has been successfully treated in the ongoing Phase I clinical trial of HG-CT-1, the Company’s proprietary Chimeric Antigen Receptor T-cell (CAR-T) therapy for relapsed/refractory acute myeloid leukemia (R/R AML) in adults. HEMO said “The successful treatment of the third patient marks another important milestone for Hemogenyx Pharmaceuticals and for patients battling relapsed or refractory AML. We are encouraged by the favorable safety profile observed to date, together with the early signals of efficacy.”
Comment: It can be observed that HEMO is curing the world, one patient at a time. It has been richly rewarded for this, with the stock rising 10x off the back of this, something which has been tracked here at Zakstraderscafe.com uniquely and accurately.
Altona Rare Earths (REE), a resource exploration and development company focused on critical raw materials in Africa, updated on Monte Muambe’s fluorspar and gallium drilling and resource estimate plans. REE said “The results we have obtained so far now justify reporting gallium in the upcoming JORC fluorspar MRE. This will allow Altona to quantify this commodity, and to substantially increase the value of this asset for the Company’s shareholders.”
Comment: REE continues to be a decent play on the rise and rise of the world’s appreciation of rare earths, with the run up to a MRE being a decent driver for ongoing share price recovery.
TruFin (TRU) announced its Interim Results for the six months ended 30 June 2025 (Unaudited). Gross revenue for the Group increased 42% to £36.0m (H1 2024: £25.3m). Net revenue increased 29% to £15.4m (H1 2024: £11.9m). Adjusted EBITDA increased 136% to £6.9m (H1 2024: £2.9m). Profit before tax (“PBT”) increased 2,711% to £4.6m (H1 2024: £0.2m). TRU said “Having grown revenues in the first half last year by more than 200%, it is very pleasing to report a further 42% growth in revenue in the first half of 2025. It is even more pleasing to report on the operational leverage that is coming through, with EBITDA and PBT increasing by 136% and 2,711% respectively. And with a strong start to the second half, we have much to be excited about.”
Comment: Although no one likes a show off, it would appear that TRU has plenty to brag about. The shares have more than doubled over the past year, and in the wake of this update are revved up to deliver more on the upside.
Nexteq (NXQ), a leading technology solutions provider to customers in multiple markets, announced that its Quixant brand, which serves the land-based gaming market, has secured its entrance into the Brazil market, with the first mass production purchase order from a Brazilian state video lottery operator. This follows the Group’s launch of a specifically engineered solution developed in anticipation of this new and rapidly emerging market opportunity, utilising the Group’s market leading computer engineering capabilities.
Comment: The big turnaround in NXQ shares happened this spring, and with news like today’s we are set for the stock to recoup much more of the market cap that was lost in the past couple of years. NXQ looks set to be a great niche/specialist player.
Galliford Try (GFRD) announced its annual results for the year ended 30 June 2025. GFRD said it was “Well placed to support the Government’s commitment to invest in the UK’s infrastructure and affordable housing. Confident outlook with a high quality £4.1bn order book (2024: £3.8bn) across our diversified growth sectors and areas of planned Government and regulated spend. High visibility of future work streams and revenue with 92% and 75% of projected FY26 and FY27 revenue secured.”
Comment: There is nothing better to be a company with a prime position on the government’s public spending gravy train, where tenders are effectively jobs for the boys and girls. The only issues here are how unreliable the current government is, and how skint. Oh, and whether it will actually be around this time next year.
Hercules (HERC), a leading technology enabled labour supply company for the UK infrastructure and construction sectors, announced a series of new contract awards from its clients in the UK water sector during the past two quarters. The new agreements total c.£6.5 million in value over their duration. The award of these contracts from Galliford Try, Costain, Tilbury Douglas, MWH Treatment, Glanua and Thames Water demonstrates the strength of Hercules’ position within the UK water sector as a trusted delivery partner.
Comment: It would appear that HERC is one of the newer government gravy train, public spending bandwagon brigade members, so in a great place. It would appear that it is the outsourcer for the outsourcer. All of this puts the cost up for the taxpayer, and is all the better for the contractor. But who cares about the taxpayer getting ripped off?
Moonpig Group (MOON), the leading online greeting card and gifting platform in the UK and the Netherlands, is holding its Annual General Meeting today. In advance of this, the Group provided an update on its performance for the current financial year (commencing 1 May 2025) to date. Overall, Group trading momentum has continued through the start of the year, in line with expectations, and we remain on track to deliver our FY26 guidance. MOON said “it continues to deliver consistent revenue growth at approximately 10% year on year. Greetz trading has improved sequentially, with revenue now showing modest year on year growth on both a reported and constant currency basis.”
Comment: Whenever one sees a RNS of a company with an improved performance, but cannot work out who would buy the product, or why, you know that the management of said company is top notch. This would appear the case at MOON.
Quadrise (QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, announced the successful completion of proof-of-concept and emissions testing programmes for its MSAR® and bioMSAR™ fuels at the Sparkle Power SA plant in El Giral, Panama. These trials mark the first successful application of MSAR® and bioMSAR™ on Everllence (formerly MAN Energy Solutions) 4-stroke engines, expanding the commercial potential of these fuels across additional engine types in energy-intensive sectors seeking cost-effective decarbonisation solutions.
Comment: Shares of QED are having to undertake a great recovery effort having peaked at the start of the year at 8p. That said, the decarbonisation of shipping, one of the worst polluting activities, has been and remains a rich vein for those who are able to address the issue.
Feedback (FDBK), the clinical infrastructure specialist, announced its audited results for the 12 months to 31 May 2025. Revenue of £0.89m (2024: £1.18m). Sales were £0.89m (2024: £0.95m); Bleepa contributed 90%. EBITDA loss of £3.06m (2024: £2.73m). Raised gross proceeds of approximately £6.1 million via a Placing and Retail Offer and completed a share capital reorganisation in November 2024.
Comment: If businesses could be financed as easily and happily as FDBK has been, none of them would ever go bust. Bleepa or no Bleepa, FDBK still needs to prove it is a significant, scalable concern.
Zenith Energy (ZEN), the listed international energy production and development company, announced the signing of an agreement to acquire a solar energy development project located in the Puglia region of Italy by its wholly-owned Italian subsidiary created to manage its solar energy portfolio, WESOLAR S.R.L. The Puglia Acquisition will have a total installed capacity of approximately 6 MWp.
Comment: ZEN continues to build up its renewable energy strategy, while we wait for it to regroup regarding its Tunisia arbitration. It is clear that the company is determined to ensure that whatever the scenario on the claim, it will have a significant energy business under its belt.
GSTechnologies Limited (GST), the fintech company, provided an update on the Company’s Bitcoin holding following the formal adoption of a Bitcoin treasury reserve policy, as announced on 25 June 2025. The Company currently holds approximately 8.8 Bitcoin in its treasury, acquired at an average purchase price of US$113,592.94 per Bitcoin, for an aggregate cost of US$999,617.90. The total value of the Company’s Bitcoin holding is now approximately US$1.02 million.
Comment: Three months ago the market would have gone wild with a BTC update from a company. Now it barely causes a ripple. At least the shares are back from suspension.
Fusion Antibodies (FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, provides an update to the OptiMAL® project being performed under the collaboration agreement (the “Agreement”) with the National Cancer Institute. The NCI Research Collaboration, which was originally announced on 28 November 2023, is due to continue until November 2025. However, the NCI has asked to extend its use of the OptiMAL® platform for use against further targets in the coming years. Negotiations are now underway to establish mutually agreeable terms for an extended agreement.
Comment: A great RNS, which is the equivalent of saying to someone, if we loved you before, we now want to marry you and have your babies. One would expect FAB shares to deliver another strong leg to the upside. Above 14p we have been looking for 21p- 22p in coming weeks / days. Yes, like HEMO, this is another stock whose ascent has been tracked / predicted from the start of the rally here at Zakstraderscafe.com.
SolGold (SOLG) announced that drill hole results received for holes 57, 59, 60, 61, 62, 63, 64, and 65 support the emerging strategy for the development of early-stage open-cut resources at Tandayama America, 3 km north of the Alpala resource and reserves on the Company’s 100% owned Cascabel porphyry copper-gold Project in Northern Ecuador. SOLG said “I am pleased to see the mineralisation expanding with more high-grade zones. Tandayama West looks interesting and could potentially add significant life to the open pit complex, further de-risking the overall project as we embark on commencing early works at Alpala.”
Comment: Shares of SOLG have nearly tripled since July, something which has been delivered by not only the gold price surge, but also the way that the company has been reporting strong operational progress, such as today’s.
Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.
